Sparrow Pharmaceuticals Presents Novel Data on Clofutriben (SPI-62) Reducing Glucocorticoid Toxicities with a Low Risk of Adrenal Insufficiency at the 2024 Annual Endocrine Society Conference
Business Wire
PORTLAND, Ore.--(BUSINESS WIRE)--Sparrow Pharmaceuticals, announced today that it presented interim analyses of ongoing clinical..